Evidence map›Paper›PMID 34404481›Full record

ArticleHereditas2021

Modulating the bicoid gradient in space and time.

Xiaoli Cai, Inge Rondeel, Stefan Baumgartner

Open access · goldAbstract read
In one paragraph

Article in Hereditas, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 3 countries.

Xiaoli CaiDepartmentof Experimental Medical Sciences, Lund University, BMC D10, 22184, Lund, Sweden.
Inge RondeelDepartmentof Experimental Medical Sciences, Lund University, BMC D10, 22184, Lund, Sweden.
Stefan BaumgartnerDepartmentof Experimental Medical Sciences, Lund University, BMC D10, 22184, Lund, Sweden. Stefan.Baumgartner@med.lu.se.ORCID http://orcid.org/0000-0001-5320-8321
Lund University · SE

Funding

Erik-Philip-Sörensen-Stiftelse 2019Nilsson-Ehle Stiftelse 2019Pia Ståhl Stiftelse 2019Vetenskapsrådet 2010
6 · The paper itself

Abstract

backgroundThe formation of the Bicoid (Bcd) gradient in the early Drosophila is one of the most fascinating observations in biology and serves as a paradigm for gradient formation, yet its mechanism is still not fully understood. Two distinct models were proposed in the past, the SDD and the ARTS model.

resultsWe define novel cis- and trans-acting factors that are indispensable for gradient formation. The first one is the poly A tail length of the bcd mRNA where we demonstrate that it changes not only in time, but also in space. We show that posterior bcd mRNAs possess a longer poly tail than anterior ones and this elongation is likely mediated by wispy (wisp), a poly A polymerase. Consequently, modulating the activity of Wisp results in changes of the Bcd gradient, in controlling downstream targets such as the gap and pair-rule genes, and also in influencing the cuticular pattern. Attempts to modulate the Bcd gradient by subjecting the egg to an extra nuclear cycle, i.e. a 15

conclusionsOur analysis demonstrates that Bcd gradient formation is far more complex than previously thought requiring a revision of the models of how the gradient is formed.

Indexed as

AnimalsCyclin BDrosophilaDrosophila ProteinsGene Expression Regulation, DevelopmentalHomeodomain ProteinsPoly APolynucleotide AdenylyltransferaseRNA, MessengerTrans-Activatorsbcd protein, DrosophilaCycB protein, DrosophilaCyclin BDrosophila ProteinsHomeodomain ProteinsPoly APolynucleotide AdenylyltransferaseRNA, MessengerTrans-Activatorswisp protein, Drosophila

Identifiers

PMID34404481
PMCPMC8371787
OpenAlexW3194804169

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.